Wednesday, November 20, 2024
HomeNews

News

Gracell Biotechnologies Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced the...

EHA 2022 | Ascentage Pharma Releases Encouraging Results of Bcl-2 Inhibitor Lisaftoclax (APG-2575)

Ascentage Pharma , a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that it...

Innovent Releases Results of High-dose Cohorts in Phase 1 Clinical Study of Mazdutide (IBI362) in Chinese Adults

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other...

Mnemo Therapeutics Launches RHU Project in Collaboration with Leading European Research Partners

Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, announced the kick-off of their participation in the prestigious Hospital-University Research in Health (RHU) program. Designed...

Davis Wright Tremaine Combines With McGonigle, One of the Nation’s Preeminent Financial Services Boutiques

Davis Wright Tremaine LLP is combining with McGonigle, P.C., one of the nation’s preeminent financial services boutiques. With McGonigle’s 44 lawyers, Davis Wright more...
0FansLike
0FollowersFollow
spot_img

Hot Topics